RhumbLine Advisers’s SciSparc SPRC Stock Holding History

RhumbLine Advisers’s Portfolio SPRC Stock Details SPRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Hold	0	–	–	–	4131
2025 Q3	–	Hold	0	–	–	–	4112
2025 Q2	–	Hold	0	–	–	–	4136
2025 Q1	–	Sell	-18	Closed	-$1.63K	–	4125
2024 Q4	$1.25K	Hold	18	–	–	﹤0.01%	4062
2024 Q3	$841	Hold	18	–	–	﹤0.01%	4103
2024 Q2	$2.87K	Hold	18	–	–	﹤0.01%	4154
2024 Q1	$6.13K	Buy	+18	New	+$12.3K	﹤0.01%	3950
2023 Q4	–	Hold	0	–	–	–	4239
2023 Q3	–	Hold	0	–	–	–	4280
2023 Q2	–	Hold	0	–	–	–	4317

Other funds holding SPRC

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SIS

Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

RhumbLine Advisers's SPRC Position: Q4 2025 in Review

RhumbLine Advisers held its SciSparc (SPRC) position steady in Q4 2025 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4131.

RhumbLine Advisers first reported a position in SPRC in Q1 2024 and has held it in 4 quarters since. The position peaked at $6.13K in Q1 2024. 6 funds tracked by Wall St. Rank hold SPRC as of Q4 2025.

RhumbLine Advisers held 0 shares of SciSparc worth $1 as of Q4 2025.
RhumbLine Advisers left its SciSparc share count unchanged in Q4 2025.
SciSparc made up ﹤0.01% of RhumbLine Advisers's portfolio in Q4 2025, its #4131 holding.
RhumbLine Advisers first reported a position in SciSparc in Q1 2024 and has held it in 4 quarters since.
RhumbLine Advisers's SciSparc position peaked at $6.13K in Q1 2024.
6 funds tracked by Wall St. Rank held SciSparc as of Q4 2025.

Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.